Disc Medicine clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Study of Bitopertin in Participants With EPP or XLP (APOLLO)NCT06910358DISC-1459Completed2026-09-08Actual

Phase 2 / 3 1 trial

Phase 2 3 trials

Phase 1 / 2 1 trial

TrialDrugs studiedStatusPrimary completion
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaNCT05320198DISC-0974Recruiting2027-05Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-02-13DayDISC-1459Disc Medicine, Inc · IRONFDA complete response letterComplete response letterNot specifiedOpen original source
Read source excerpt

{"application_number": ["NDA 220707"], "letter_date": "02/13/2026", "letter_type": "COMPLETE RESPONSE", "company_name": "Disc Medicine, Inc.", "file_name": "CRL_NDA220707_20260213.pdf"}

First seen: 26 Sep 2026 · Evidence last checked: 26 Sep 2026

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2026. After: 8 Sep 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 150 participants (planned). After: 183 participants (actual).

Primary completion date changed

Before: Oct 2026. After: Sep 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source